Oculis Holding AG (OCS) shareholders
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.51−0.12 (-1.57%)
Close on Nov 17, 2026Market cap $451.27MP/E –Yield –
Ownership
Who owns Oculis's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| LSP 7 Management B.V. Joint filing with LSP 7 Cooperatieve U.A. (11.80%) | 6,950,294 | 11.80% | 13G (passive) amendment | Mar 31, 2026 |
| LSP 7 Cooperatieve U.A. Joint filing with LSP 7 Management B.V. (13.80%) | 5,752,894 | 13.80% | 13G (passive) amendment | Dec 31, 2024 |
| BVCF IV GP, Ltd. Joint filing with Bvcf Iv, L.P. (5.05%), Beyeotech (5.05%) and 1 more | 2,191,810 | 5.05% | 13G (passive) amendment | Nov 27, 2024 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
2M shares short
Days to cover
5.6
At 0M shares a day
Change since last report
-11.3%
From 2M shares
Short volume, 20 days
43.7%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Oculis's stock actually held short. Settlement fails (shares not delivered on time) peaked at 48,504 shares on Aug 27, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sherif Riad Officer, CEO | Mar 9, 2026 | 25,000 | $660.00K | Mar 9, 2026 | Issuance of earnout shares of Oculis Holding AG |
| Christina Ackermann Director | Oct 9, 2025 | 7,460 | $148.23K | Oct 9, 2025 | Exercise of Stock Options |
| Sherif Riad Officer, CEO | Sep 23, 2025 | 25,000 | $442.50K | Sep 23, 2025 | Issuance of earnout shares of Oculis Holding AG |
| Sherif Riad Officer, CEO | Mar 14, 2025 | 25,000 | $466.50K | Mar 14, 2025 | Issuance of earnout shares of Oculis Holding AG |
See a number that looks wrong?